BioSpace News Archive

Business

EmpiraMed’s CMO Selected to Share His Unique Perspective on Effective Patient Engagement Strategies

Best-in-Class Real World Evidence Metrics Disclosed in New Managed Care Article

October 30, 2018
·
2 min read
Business

Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2019

Strong launch quarter for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in U.S. with $14 million in net sales

October 30, 2018
·
21 min read
Biotech Beach

The Prostate Cancer Foundation Awards $5.5 Million To PCF Challenge Award Recipients To Advance Prostate Cancer Research

Six New Teams Will Focus on Highly Innovative New Therapeutic Strategies for Advanced Prostate Cancer

October 30, 2018
·
4 min read
Biotech Bay

ValGenesis Releases Next Generation VLMS 4.0 with Customer-Driven Enhancements and Built-in Best Practices for Paperless Validation

ValGenesis Continues its Rapid Pace of Innovation to Deliver New Levels of Collaboration, Data Integrity, Risk Management and Compliance in Validation Lifecycle Management Process for Life Sciences

October 30, 2018
·
4 min read
Business

Genomic Health to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 6, 2018

Genomic Health, Inc. today announced that the company will host a conference call and webcast on Tuesday, November 6 at 4:30 p.m. Eastern Time to discuss its third quarter 2018 financial results.

October 30, 2018
·
2 min read
Business

Audentes Therapeutics to Release Third Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, November 6, 2018

Audentes Therapeutics, Inc. will host a conference call and webcast to report its third quarter 2018 financial results and provide a corporate update on Tuesday, November 6, 2018.

October 30, 2018
·
1 min read
BioMidwest

Experts Examine Data Integration for Solid Organ Transplant Programs at OTTR User International Conference

OTTR recently hosted an international user conference that brought industry leaders together to discuss key management aspects related to solid organ transplant programs, including systems that facilitate the exchange of electronic health data.

October 30, 2018
·
2 min read
Business

Axial Biotherapeutics Strengthens Senior Management Team with Appointment of Jeff Young as Chief Financial Officer

Axial Biotherapeutics, a biotechnology company building a unique class of microbial-inspired therapeutics for neurological diseases, today announced the appointment of Jeffrey Young as the company’s first Chief Financial Officer (CFO).

October 30, 2018
·
3 min read
Business

Acerus Announces Executive Leadership Changes in Corporate Finance

– Robert Motz joins Acerus as Chief Financial Officer –

October 30, 2018
·
3 min read
Biotech Bay

BioTime to Report Third Quarter 2018 Financial Results on November 8th, 2018

BioTime, Inc. today announced that it will report its third quarter 2018 financial and operating results on Thursday, November 8th, 2018.

October 30, 2018
·
2 min read